| abstract |
The present invention relates to an oil-in-water nanoemulsion composition for MRI, including: an aqueous phase which is 70 to 90 wt % of the composition, advantageously 75 to 85 wt %, more advantageously 78 to 82 wt %; a lipid phase including an oil, which is 9.5 to 29.5 wt % of the composition, advantageously 14 to 25 wt %, more advantageously 17 to 21 wt %; a surfactant at the interface between the aqueous and lipid phases, the surfactant including at least one amphiphilic paramagnetic metal chelate and optionally an amphiphilic lipid; the total content by weight of the surfactant relative to the oil being 4 to 10 wt %, advantageously 5 to 8 wt %; the total content by weight of the surfactant relative to the composition being 0.35 to 2.95 wt %, advantageously 0.5 to 2 wt %; the oil including at least 70 wt %, advantageously at least 80 wt %, more advantageously at least 95 wt %, in particular at least 97 wt %, of C6-C18 saturated fatty acids, advantageously C6-C14, and more advantageously C6-C10. |